M12 M1 Beauty AG

EQS-News: Invitation to the virtual AlsterResearch Healthcare Pop-Up Conference on 23 January 2024 at 1:30 pm

EQS-News: M1 Kliniken AG / Key word(s): Conference
Invitation to the virtual AlsterResearch Healthcare Pop-Up Conference on 23 January 2024 at 1:30 pm

22.01.2024 / 10:26 CET/CEST
The issuer is solely responsible for the content of this announcement.


Invitation to the virtual AlsterResearch Healthcare Pop-Up Conference
on 23 January 2024 at 1:30 pm

As part of the AlsterResearch Healthcare Pop-Up Conference, we cordially invite you to our virtual roundtable on Tuesday, 23 January 2024 at 13:30 (CET). Attila Strauss, Co-CEO of M1 Kliniken AG, and Kilian Brenske, Co-CEO of M1 Kliniken AG, will give you a company update and an outlook for the coming months in a presentation. Afterwards, the gentlemen will be available to answer your questions. The presentation will be held in German.

You can register for the AlsterResearch Healthcare Pop-Up Conference at the following link:


We look forward to meeting you!


About M1 Kliniken AG
M1 Kliniken AG is the leading fully integrated provider of aesthetic medical health services in Europe. In the aesthetic and surgical fields, the group offers products and services with the highest quality standards. Currently, under the brand "M1 Med Beauty," beauty medical treatments are offered at 58 specialist centres. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating rooms and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been driving internationalisation and is currently present in ten countries.




Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M:


22.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: +49 (0)30 347 47 44 14
Fax: +49 (0)30 347 47 44 17
E-mail:
Internet: -kliniken.de
ISIN: DE000A0STSQ8
WKN: A0STSQ
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1820085

 
End of News EQS News Service

1820085  22.01.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1820085&application_name=news&site_id=research_pool
EN
22/01/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on M1 Beauty AG

 PRESS RELEASE

EQS-News: M1 Kliniken AG publishes preliminary figures for financial y...

EQS-News: M1 Kliniken AG / Key word(s): Preliminary Results/Annual Results M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million 18.04.2024 / 08:34 CET/CEST The issuer is solely responsible for the content of this announcement. M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million and the Group's equity increases to € 143.7 ...

 PRESS RELEASE

EQS-News: M1 Kliniken AG veröffentlicht vorläufige Zahlen zum Geschäft...

EQS-News: M1 Kliniken AG / Schlagwort(e): Vorläufiges Ergebnis/Jahresergebnis M1 Kliniken AG veröffentlicht vorläufige Zahlen zum Geschäftsjahr 2023: M1 weiter auf Wachstumskurs: Umsatzsteigerung von über 10 % auf 316,3 Mio. Euro; EBIT steigt um 68 % auf 15,7 Mio. Euro 18.04.2024 / 08:34 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. M1 Kliniken AG veröffentlicht vorläufige Zahlen zum Geschäftsjahr 2023: M1 weiter auf Wachstumskurs: Umsatzsteigerung von über 10 % auf 316,3 Mio. Euro; EBIT steigt um 68 % auf 15,7 Mio. Euro und Kon...

 PRESS RELEASE

EQS-News: M1 Kliniken AG: Private equity interested in beauty segment,...

EQS-News: M1 Kliniken AG / Key word(s): Miscellaneous M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024 16.02.2024 / 15:10 CET/CEST The issuer is solely responsible for the content of this announcement. M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024 Management is open to interested parties Valuations in the peer group of up to 30 times the annual EBITDA M1 Kliniken AG expects EBITDA of over EUR 27 million in 2024 Berlin, 16 February 2024 - M1 Kliniken ...

 PRESS RELEASE

EQS-News: M1 Kliniken AG: Interesse von Private Equity an Beauty-Segme...

EQS-News: M1 Kliniken AG / Schlagwort(e): Sonstiges M1 Kliniken AG: Interesse von Private Equity an Beauty-Segment, EBITDA von über 27 Mio. EUR in 2024 erwartet 16.02.2024 / 15:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. M1 Kliniken AG: Interesse von Private Equity an Beauty-Segment, EBITDA von über 27 Mio. EUR in 2024 erwartet Management steht Interessenten ergebnisoffen gegenüber Bewertungen in der Peer-Group von bis zu 30-fachen des jährlichen EBITDA M1 Kliniken AG erwartet EBITDA von über 27 Mio. EUR in 2024 Berlin, 16.0...

 PRESS RELEASE

EQS-News: Management Board of M1 Kliniken AG acquires 1.5 million shar...

EQS-News: M1 Kliniken AG / Key word(s): Investment Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard 05.02.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. The two members of the Management Board of M1 Kliniken AG, Mr Attila Strauss and Mr Kilian Brenske, acquired a total of 1.5 million shares in the company from MPH Health Care AG on 2 February 2024. The Co-CEOs justify the share purchase with their confidence in the long-term growth prospects of M1 Klinik...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch